Mr. Gyselen is partner at Arnold & Porter Kaye Scholer (Brussels). His antitrust practice encompasses advice and representation before EU and national agencies on merger control, abusive conduct, cartels, other restrictive practices and state aids. In light of his previous government experience, his expertise is focused in areas where antitrust and regulatory issues are intertwined such as financial services and pharmaceuticals ; distribution practices involving manufacturers of fast moving consumer goods such as food ; and cartel work including leniency applications. Mr. Gyselen joined the firm in July 2004 after twenty years of public service at various EU institutions. He spent most of his time at the European Commission, where he was a member of the Legal Service in the early years of his career and later held several senior positions in the Directorate-General for Competition (DG COMP). His career at the Commission was interrupted by a three year secondment to the European Court of Justice where he was a law clerk to the then Belgian judge. During his four years as special assistant to the Director-General in DG COMP (1990-1994), he oversaw the entire range of EU competition policy activities, including the introduction of EC merger control, and acted as liaison officer between DG COMP and the Commissioner in charge of competition policy and his personal staff. Between 1994 and 2004, he played a key role in many leading antitrust cases. In the area of abusive conduct, these included Coca Cola (rebates, exclusive dealing, category management) - a case which led him to write an comprehensive article on rebates that received high visibility in the business community. Mr. Gyselen was also case manager in a dozen cartel cases in the financial services, food and agricultural sectors. In the pharmaceutical area, he cleared a number of joint ventures on the basis of a reasoning that was later incorporated in the Commission’s guidelines on horizontal restraints.
16185 | Évènements
In the past ten years or so, e-Competitions’ Bulletin has regularly reported about pharmaceutical merger control decisions or judgments from various jurisdictions in the world. Many of these cases involved remedies that were meant to address the antitrust concerns that the competent competition (...)
Alors que la Commission européenne étudie une éventuelle révision du VBER et des lignes directrices verticales et évalue les différentes options politiques proposées, ce volume vise à réfléchir à certaines des questions et sujets pertinents du VBER, certains plus controversés que d’autres, mais tous ayant (...)
Les premières réflexions de cette journée consacrée au traitement des restrictions verticales portent sur leurs différences par rapport aux restrictions horizontales. En théorie, la distinction est simple et le traitement de ces deux formes de restrictions est fortement différencié. Mais la vie (...)
Cette quatrième table-ronde du colloque "Quel avenir pour les restrictions verticales ?" (Paris, 23 mai 2008) est dédiée à l’étude de l’effet de forclusion des restrictions verticales. La question se pose dans les différents champs du droit de la concurrence - pratiques restrictives, pratiques (...)
Cet article analyse quelques unes des décisions importantes de la Cour de Justice des Communautés Européennes et de la Commission en matière d’abus de position dominante et de droits de propriété intellectuelle. La Cour de Justice a reconnu que le titulaire d’un droit de propriété intellectuelle, (...)